Navigation Links
ViroPharma Licenses Rights From Intellect Neurosciences for Product Candidate for Friedreich's Ataxia
Date:9/30/2011

EXTON, Pa., Sept. 30, 2011 /PRNewswire/ -- ViroPharma Incorporated (NASDAQ: VPHM) today announced the license of worldwide rights from Intellect Neurosciences, Inc. (OTCBB: ILNS) to its clinical stage drug candidate, OX1, being developed for the treatment of Friedreich's Ataxia (FA), a rare, hereditary, progressive neurodegenerative disease.

OX1, or indole-3-propionic acid (IPA), is a naturally occurring, small molecule that has potent anti-oxidant properties that can protect against neurodegenerative disease.  In a recent Phase 1 safety and tolerability study conducted in the Netherlands, OX1 was demonstrated to be safe and well tolerated at all dose levels tested. ViroPharma expects to initiate a phase 2 study within 12 to 18 months after completion of longer term toxicology studies. ViroPharma intends to file for Orphan Drug Designation upon review of the phase 2 proof of concept data.

Under the terms of the agreement, ViroPharma has exclusive worldwide rights to develop and commercialize OX1 for the treatment, management or prevention of any disease or condition covered by Intellect's patents. ViroPharma paid Intellect Neurosciences a $6.5 million up-front licensing fee and will pay additional milestones based upon defined events.  The maximum of these milestone payments assuming successful advancement to market could amount to $120 million. The company will also pay a tiered royalty of up to a maximum percentage of low teens, based on annual net sales.

"The mission of ViroPharma is to improve the health of patients suffering from serious diseases and unmet medical needs, and Friedreich's Ataxia clearly fits in that class," said Vincent Milano, ViroPharma's chief executive officer.  "FA robs children and young adults of muscle coordination leading to loss of mobility, energy, speech, and hearing, and presents a significant risk of diabetes an
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ViroPharma Announces Additional Securities Repurchase Program
2. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
3. ViroPharmas Buccolam® (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
4. ViroPharma to Participate in the Stifel Nicolaus 2011 Healthcare Conference
5. ViroPharma Announces Positive CHMP Opinion for Buccolam® (Midazolam, Oromucosal Solution) in the European Union
6. ViroPharmas Cinryze® (C1 Inhibitor [Human]) Granted European Marketing Authorization for Hereditary Angioedema (HAE)
7. ViroPharma to Participate in the Jefferies 2011 Global Healthcare Conference
8. ViroPharma Launches Swell, an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema
9. ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
10. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
11. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 6, 2015 According to ... Isolation Market by Technology (Precipitation, Dialysis, Electrophoresis, Western ... (Instruments, Kits, Reagents, Resins) by Application & End ... MarketsandMarkets,  the global Protein Purification and Isolation Market ... and is expected to reach $ 6,370 Million ...
(Date:5/6/2015)... -- Neuralstem, Inc. (NYSE MKT: CUR), a biopharmaceutical company ... and cell therapy treatments for central nervous system diseases, ... to the position of Chief Financial Officer, effective May ... Jones brings to the position more than 25 ... recently, Mr. Lloyd Jones served as Chief ...
(Date:5/6/2015)... ST. LOUIS , May 6, 2015   ... science and high technology company, today announced a $50,000 ... , a large-scale initiative to replicate key findings from ... The project is a collaboration between the online research ... for Open Science and the open-access journal ...
Breaking Medicine Technology:Protein Purification and Isolation Market Worth $6,370 Million by 2020 2Protein Purification and Isolation Market Worth $6,370 Million by 2020 3Protein Purification and Isolation Market Worth $6,370 Million by 2020 4Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3
... Inc. (Nasdaq: ANTH ), a biopharmaceutical company ... autoimmune disorders, today announced that it has appointed Dr. ... "Bogdan,s extensive global regulatory expertise and broad industry ... continue to navigate the evolving FDA regulatory landscape," said ...
... CLARK, N.J., March 5, 2012  Kerri Eckroat, RN, BSN, ... member of SurroundHealth , a free online community ... Eckroat said: "I believe that educating myself is crucial ... patients deserve the best. By learning from other healthcare ...
Cached Medicine Technology:Dr. Bogdan Dziurzynski Joins Anthera Pharmaceuticals Board of Directors 2Dr. Bogdan Dziurzynski Joins Anthera Pharmaceuticals Board of Directors 3SurroundHealth Online Community Reaches 1,000 Members 2SurroundHealth Online Community Reaches 1,000 Members 3
(Date:5/6/2015)... Hope For The Warriors® and American Legion Post ... New York Athletic Club on April 21, 2015. All ... a national nonprofit dedicated to restoring a sense of ... our service members and our military families. , Casino ... nationwide military families. The Barry Fixler Foundation/Semper Cool (fixlerfoundation.org) ...
(Date:5/6/2015)... May 06, 2015 The American Water ... period for its prestigious Integrated Water Resources Management (IWRM) ... approach to water resources projects. , An IWRM approach to ... establishment in 1964. In 2014, 12 projects were nominated for ... magazine features not only the 2014 AWRA IWRM Award winner ...
(Date:5/6/2015)... Boston, MA (PRWEB) May 06, 2015 Most ... years of long-term nursing or other care after age 65. ... beyond are saving for it or even talking about it, ... By not planning, people risk two problems. One is losing ... off to their families," says Dr. David Grabowski, a professor ...
(Date:5/6/2015)... Qualidigm , the national ... healthcare executive Ann Olson, RN, BSN, as a ... Qualidigm’s growing home healthcare services and develop strategic ... quality, safety, and cost-effectiveness of healthcare through transformational ... HealthCare of North Haven, Inc., a full-service home ...
(Date:5/6/2015)... NY (PRWEB) May 06, 2015 ... long-standing organization dedicated to activating and celebrating public ... Champion organization, Highmark Health, as an Outstanding Employee ... with the Jefferson Awards Foundation, are dedicated to ... For nearly a decade, Highmark Health has recognized ...
Breaking Medicine News(10 mins):Health News:4th Annual Casino Night Draws Support for Military Families in New York City Region 2Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Start Planning Now for Long-Term Care, from the May 2015 Harvard Health Letter 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:The Jefferson Awards Foundation Honors Highmark Health 2Health News:The Jefferson Awards Foundation Honors Highmark Health 3Health News:The Jefferson Awards Foundation Honors Highmark Health 4
... it may be better than standard oxygen therapy, study suggests ... that a mechanical ventilator can ease suffering and help lung ... A large percentage of these patients didn,t want to have ... wear an oxygen mask. But those who were willing to ...
... in Fight Against Tobacco Recognized Nationally-, WASHINGTON, May ... the Central Regional Youth Advocate of the Year,by the ... fight,against tobacco. Michelle is being honored at a gala ... national winner, international grant winner,three other regional winners and ...
... is Possible!, DETROIT, Mich., May 19 Patrick Hendry ... of bipolar disorder.,He spent seven years in and out of ... went so far as trying,electro-convulsive therapy, similar to shock therapy., ... my life. You feel,hopeless and lost," said Hendry. "It,s difficult ...
... WASHINGTON, May 20 Auriel Rolle-Polk, 17, of,Tallahassee, FL ... the,Year by the Campaign for Tobacco-Free Kids for her ... at a gala in the nation,s capital,on May 20 ... regional winners and a group winner., Auriel, a ...
... 20 Caraco Pharmaceutical,Laboratories, Ltd. (Amex: CPD ... its fourth quarter and fiscal year 2008 ended ... Thursday May 29, 2008., Detroit-based Caraco Pharmaceutical ... private-label,pharmaceuticals to the nation,s largest wholesalers, distributors,drugstore chains ...
... Ischemic injury to the bowel is a well known disease ... findings. A sudden drop in the colonic blood supply is ... of macrovascular mesenteric vein rarely causes ischemia of the bowel. ... by obstruction of the mesenteric and splenic veins. , ...
Cached Medicine News:Health News:Ventilator Relieves Lung Cancer Pain in Final Hours 2Health News:Ventilator Relieves Lung Cancer Pain in Final Hours 3Health News:Campaign for Tobacco-Free Kids Honors Michelle Mays of Rhinelander, WI As Youth Advocate of the Year 2Health News:Man who Lost Everything Comes to Detroit to Spread Message of Hope 2Health News:Campaign for Tobacco-Free Kids Honors Auriel Rolle-Polk of Tallahassee, FL As Youth Advocate of the Year 2Health News:Caraco Pharmaceutical Laboratories, Ltd. to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29, 2008 2
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... We offer a complete line ... laboratorians state-of-the-art monoclonal and monoclonal/polyclonal ... detection of enteric pathogens in ... products for Clostridium difficile, Entamoeba ...
... The C. Difficile Tox A/B II test ... Diagnostics's exclusive Fecal-Quik-Prep device which greatly reduces ... specimens for Tox A/B II testing. The ... device that greatly reduces the amount of ...
... Our ELISA products for autoimmune testing ... ELISAs, as well as specific reflex tests ... Sm, Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 ... family includes a full line of products ...
Medicine Products: